Israel Englander Inhibrx, Inc. Transaction History

Millennium Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$32.76 - $39.56 $7.73 Million - $9.33 Million	-235,948 Reduced 90.38%	25,110 $877,000
Q4 2023 Feb 14, 2024	BUY	$14.5 - $38.0 $1.17 Million - $3.07 Million	80,710 Added 44.75%	261,058 $9.92 Million
Q2 2023 Aug 14, 2023	SELL	$16.96 - $27.82 $9.14 Million - $15 Million	-539,205 Reduced 74.94%	180,348 $4.68 Million
Q1 2023 May 15, 2023	BUY	$18.45 - $27.14 $400,678 - $589,399	21,717 Added 3.11%	719,553 $13.6 Million
Q4 2022 Feb 14, 2023	BUY	$20.18 - $33.33 $4.06 Million - $6.71 Million	201,410 Added 40.57%	697,836 $17.2 Million
Q3 2022 Nov 14, 2022	SELL	$11.58 - $24.73 $5.22 Million - $11.1 Million	-450,605 Reduced 47.58%	496,426 $8.91 Million
Q2 2022 Aug 15, 2022	BUY	$8.52 - $25.26 $8.07 Million - $23.9 Million	947,031 New	947,031 $10.7 Million
Q4 2021 Feb 14, 2022	SELL	$26.75 - $46.02 $1.33 Million - $2.28 Million	-49,634 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$25.18 - $37.81 $6.74 Million - $10.1 Million	-267,767 Reduced 84.36%	49,634 $1.65 Million
Q2 2021 Aug 16, 2021	BUY	$14.69 - $27.52 $3.44 Million - $6.45 Million	234,383 Added 282.33%	317,401 $8.74 Million
Q1 2021 May 17, 2021	BUY	$16.27 - $41.26 $174,316 - $442,059	10,714 Added 14.82%	83,018 $1.67 Million
Q4 2020 Feb 16, 2021	BUY	$15.96 - $50.0 $73,862 - $231,400	4,628 Added 6.84%	72,304 $2.38 Million
Q3 2020 Nov 16, 2020	BUY	$16.77 - $20.65 $1.13 Million - $1.4 Million	67,676 New	67,676 $1.22 Million

18.6K

Ticker INBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,057,700
Market Cap $550M
Description
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.